SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cosmo Battinelli

(Last)

(First)

(Middle)

222 MERCHANDISE MART PLAZA

SUITE 2024

(Street)

CHICAGO

60654

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/12/2011

3. Issuer Name and Ticker or Trading Symbol
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. [ MDRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Support

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	19,783⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	⁽²⁾	08/14/2015	Common Stock	12,000⁽²⁾	$19.25	D
Stock Option	⁽³⁾	11/16/2016	Common Stock	12,600⁽³⁾	$16.78	D
Stock Option	08/14/2010	08/14/2015	Common Stock	12,000⁽⁴⁾	$19.25	D

Explanation of Responses:

1. Of the 19,783 shares beneficially owned, 4,402 are vested Restricted Stock Units (RSUs) granted under the Allscripts Healthcare Solutions, Inc. 1993 Stock Incentive Plan and one (1) share obtained through the reporting person's involvement in the Company's Employee Stock Purchase Plan. An additional 1,675 RSUs will vest in 2011; 4,681 RSUs will vest in 2012; 3,008 RSUs will vest in 2013; 3,008 RSUs will vest in 2014 and 3,008 will vest in 2015.

2. Received pursuant to the Agreement and Plan of Merger, dated as of June 9, 2010, among Allscripts-Misys Healthcare Solutions, Inc. (which has changed its name to Allscripts Healthcare Solutions, Inc.) ("Allscripts"), Arsenal Merger Corp. and Eclipsys Corporation (the "Merger Agreement")in exchange for a stock option to acquire 10,000 shares of Eclipsys Corporation common stock for $16.04 per share. Vests as to 200 shares monthly for sixty (60) months beginning on September 14, 2008.

3. Received pursuant to the Merger Agreement in exchange for a stock option to acquire 10,500 shares of Eclipsys Corporation common stock for $13.98 per share. Vests as to 25% of grant on November 16, 2010 and monthly thereafter for the remainder of the grant.

4. Received pursuant to the Merger Agreement in exchange for a stock option to acquire 10,000 shares of Eclipsys Corporation common stock for $16.04 per share. Options are fully vested as of August 14, 2010.

	Kathie Kittner by power of attorney for Cosmo Battinelli	07/25/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.